Impact of Intermittent Hypoxia Related to Obstructive Sleep Apnoea Syndrome on Low-Grade Inflammation in Hypertensive Patients: Potential Implications for Cardiovascular Risk

Overview

Journal Life (Basel)

Specialty Biology

Date 2024 May 25

PMID 38792613

Authors

Matthieu Hein

Benjamin Wacquier

Matteo Conenna

Jean-Pol Lanquart

Camille Point

Affiliations

Soon will be listed here.

Abstract

There is evidence for a particular relationship between low-grade inflammation (LGI) and intermittent hypoxia (IH) related to obstructive sleep apnoea syndrome (OSAS). However, despite the potential deleterious cardiovascular consequences associated with this LGI in hypertensive patients, few studies have investigated the impact of IH related to OSAS on CRP levels in this subpopulation. In total, 1404 hypertensive patients were selected retrospectively from the Sleep Laboratory database. CRP levels ≥3 mg/L but <10 mg/L were used as cut-offs to identify hypertensive patients with LGI. Logistic regressions were conducted to examine the risk of LGI associated with IH related to OSAS in hypertensive patients. LGI was frequent (33.8%) in hypertensive patients. After adjustment for confounders, multivariate logistic regressions revealed that only moderate to severe OSAS (apnoea-hypopnoea index ≥ 15/h) with high IH (oxygen desaturation index ≥ 15/h) [OR 1.51 (95% CI 1.06-2.14)] was significantly associated with LGI in hypertensive patients (-value = 0.045). Consistent with our hypothesis, our results demonstrated the existence of a particular subtype of hypertensive patients at high cardiovascular risk characterised by the presence of LGI induced by IH hypoxia related to moderate to severe OSAS, which justifies the establishment of adequate management of this pathology to allow better cardiovascular prevention in this subpopulation.

Citing Articles

Low-Grade Inflammation Associated with Major Depression Subtypes: A Cross-Sectional Study.

Bernier V, Alsaleh G, Point C, Wacquier B, Lanquart J, Loas G Brain Sci. 2024; 14(9).

PMID: 39335346 PMC: 11430340. DOI: 10.3390/brainsci14090850.

Excessive Daytime Sleepiness in Hypertensive Patients: The Role of Major Depressive Disorder.

Younes A, Point C, Wacquier B, Lanquart J, Hein M Diagnostics (Basel). 2024; 14(17).

PMID: 39272639 PMC: 11394253. DOI: 10.3390/diagnostics14171854.

References

Xie X, Pan L, Ren D, Du C, Guo Y . Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med. 2013; 14(11):1139-50. DOI: 10.1016/j.sleep.2013.07.006. View

Cortez A, Muxfeldt E, Lopes Cardoso C, Salles G . Prognostic Value of C-Reactive Protein in Resistant Hypertension. Am J Hypertens. 2016; 29(8):992-1000. DOI: 10.1093/ajh/hpw011. View

Zdrojewski T, Chwojnicki K, Bandosz P, Konarski R, Wyrzykowski B . Distribution of C-reactive protein and its relation to arterial hypertension in a country representing a high-risk region for cardiovascular diseases. Blood Press. 2006; 15(1):20-6. DOI: 10.1080/08037050500450049. View

Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A, Novo G . The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Intern Med J. 2009; 39(8):539-45. DOI: 10.1111/j.1445-5994.2009.01955.x. View

Fang M, Qian Q, Zhao Z, Zhu L, Su J, Li X . High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome. Int Heart J. 2018; 59(2):300-306. DOI: 10.1536/ihj.17-101. View

Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y . C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertens Res. 2008; 30(12):1177-85. DOI: 10.1291/hypres.30.1177. View

Rossi G, Bisogni V, Rossitto G, Maiolino G, Cesari M, Zhu R . Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension. High Blood Press Cardiovasc Prev. 2020; 27(6):547-560. PMC: 7661394. DOI: 10.1007/s40292-020-00415-9. View

Kim-Mitsuyama S, Soejima H, Yasuda O, Node K, Jinnouchi H, Yamamoto E . Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men. Sci Rep. 2020; 10(1):17040. PMC: 7550334. DOI: 10.1038/s41598-020-73905-4. View

Li F, Huang H, Song L, Hao H, Ying M . Effects of Obstructive Sleep Apnea Hypopnea Syndrome on Blood Pressure and C-Reactive Protein in Male Hypertension Patients. J Clin Med Res. 2016; 8(3):220-4. PMC: 4737033. DOI: 10.14740/jocmr2409w. View

10.

Fleetham J, Ayas N, Bradley D, Ferguson K, Fitzpatrick M, George C . Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J. 2006; 13(7):387-92. PMC: 2683294. DOI: 10.1155/2006/627096. View

11.

van der Touw T, Andronicos N, Smart N . Is C-reactive protein elevated in obstructive sleep apnea? a systematic review and meta-analysis. Biomarkers. 2019; 24(5):429-435. DOI: 10.1080/1354750X.2019.1600025. View

12.

Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O . Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020; 17(6):327-340. DOI: 10.1038/s41569-019-0326-7. View

13.

Draelants L, Point C, Wacquier B, Lanquart J, Loas G, Hein M . 10-Year Risk for Cardiovascular Disease Associated with COMISA (Co-Morbid Insomnia and Sleep Apnea) in Hypertensive Subjects. Life (Basel). 2023; 13(6). PMC: 10303626. DOI: 10.3390/life13061379. View

14.

Hein M, Lanquart J, Hubain P, Loas G . Risk of resistant hypertension associated with restless legs syndrome and periodic limb movements during sleep: a study on 673 treated hypertensive individuals. Sleep Med. 2019; 63:46-56. DOI: 10.1016/j.sleep.2019.05.013. View

15.

Berry R, Budhiraja R, Gottlieb D, Gozal D, Iber C, Kapur V . Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012; 8(5):597-619. PMC: 3459210. DOI: 10.5664/jcsm.2172. View

16.

Vu T, Liu K, Lloyd-Jones D, Stamler J, Pirzada A, Shah S . Favorable Levels of All Major Cardiovascular Risk Factors at Younger Ages and High-Sensitivity C-Reactive Protein 39 Years Later -The Chicago Healthy Aging Study. Prev Med Rep. 2015; 2:235-240. PMC: 4407275. DOI: 10.1016/j.pmedr.2015.03.012. View

17.

Wang J, Xu H, Guo C, Duan X, Hu F, Yang W . Association between severity of obstructive sleep apnea and high-sensitivity C-reactive protein in patients with hypertrophic obstructive cardiomyopathy. Clin Cardiol. 2020; 43(7):803-811. PMC: 7368348. DOI: 10.1002/clc.23385. View

18.

Delongui F, Kallaur A, Oliveira S, Bonametti A, Grion C, Morimoto H . Serum levels of high sensitive C reactive protein in healthy adults from southern Brazil. J Clin Lab Anal. 2013; 27(3):207-10. PMC: 6807483. DOI: 10.1002/jcla.21585. View

19.

Fukuoka R, Kohno T, Kohsaka S, Yanagisawa R, Kawakami T, Hayashida K . Nocturnal intermittent hypoxia and short sleep duration are independently associated with elevated C-reactive protein levels in patients with coronary artery disease. Sleep Med. 2017; 29:29-34. DOI: 10.1016/j.sleep.2016.09.012. View

20.

Allen R, Picchietti D, Garcia-Borreguero D, Ondo W, Walters A, Winkelman J . Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014; 15(8):860-73. DOI: 10.1016/j.sleep.2014.03.025. View